Get started
Author

Giovanni Battista Tura

Observed names: G B Tura, G. Tura, G.B. Tura, Gian Battista Tura, Tura, Giovanni Battista
ORCID: 0000-0002-4689-4746
Observed ORCID: 0000-0002-4689-4746
OpenAlex ID: A5046411027
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
2022 · Vassily Trubetskoy, Antonio F. Pardiñas, et al. · Nature · 3,121
PDF
Repetitive transcranial magnetic stimulation (rTMS) at high and low frequency: an efficacious therapy for major drug-resistant depression?
2005 · C. Miniussi, C. Bonato, et al. · Clinical Neurophysiology · 85
PDF
Association between the ionotropic glutamate receptor kainate 3 (GRIK3) ser310ala polymorphism and schizophrenia
2002 · S Begni, M Popoli, et al. · Molecular Psychiatry · 78
Allelic Variation in the Human Prodynorphin Gene Promoter and Schizophrenia
2002 · M. Ventriglia, L. Bocchio Chiavetto, et al. · Neuropsychobiology · 29
Sex differences in schizophrenia spectrum disorders: insights from the DiAPAson study using a data-driven approach
2025 · Alessandra Martinelli, Silvia Leone, et al. · Social Psychiatry and Psychiatric Epidemiology · 11
Clinical characteristics in long-term care psychiatric patients: A descriptive study
2008 · Anna Placentino, Luciana Rillosi, et al. · The World Journal of Biological Psychiatry · 9
Does pharmacogenetic testing optimize antidepressant effectiveness in major depressive disorder? Data from a double-blind randomized controlled trial in a real-world clinical setting
2025 · Alessandra Minelli, Stefano Barlati, et al. · European Psychiatry · 5
PDF
Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatch
2025 · Alessandro Serretti, Stefano Barlati, et al. · Journal of Affective Disorders · 4
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia
2001 · R. Zanardini, L. Bocchio Chiavetto, et al. · European Neuropsychopharmacology · 4
Suicidal behaviour in schizophrenia: A retrospective study
1999 · A.C. Altamura, S. Bignotti, et al. · European Neuropsychopharmacology · 3
Optimizing Treatment Strategies in the Bipolar Disorder Spectrum With Classical AI Approaches: Systematic Review of Performance, Bias, and Clinical Applicability
2026 · Silvia De Francesco, Damiano Archetti, et al. · JMIR Mental Health · 1
Schizophrenia and seasonality of birth: Clinical features and biological patterns
1999 · A.C. Altamura, S. Bignotti, et al. · European Neuropsychopharmacology · 1
Clinical correlates of complete versus partial remission in major depressive disorder: an exploratory analysis of three cohorts
2026 · Alessandro Serretti, Alessandra Minelli, et al. · European Neuropsychopharmacology
PDF
Polygenic liability for major depression, schizophrenia and bipolar disorder and treatment outcome across major psychiatric disorders
2026 · Alessandro Serretti, Daniel Souery, et al. · medRxiv
PDF
Reply to Letter to the Editor: Methodological considerations regarding confirmatory claims and multiple comparisons in the PANDORA trial symptom-remission analysis
2026 · Maria Luca, Alessandro Serretti, et al. · Journal of Psychiatric Research
Mild motor signs in major depressive disorder: prevalence and clinical profile
2026 · Antonina Luca, Alessandro Serretti, et al. · The European Journal of Psychiatry
Utility of pharmacogenetic testing to optimise antidepressant treatment in major depressive disorder: preliminary data from a randomised controlled trial
2024 · V. Menesello, A. Minelli, et al. · Neuroscience Applied
Exome analysis on major depressive disorder patients to identify novel genetic variants associated with pharmacogenetic response
2024 · A. Magistrali, S. Bignotti, et al. · Neuroscience Applied
CYP2D6 and CYP2C19 pharmacogenetic gene variants in major depressive disorder Italian cohort patients
2023 · V. Menesello, G. Pizzoleo, et al. · Neuroscience Applied
P.0106 Pharmacogenetic gene variants in treatment-resistant depression: preliminary results of a pilot study
2021 · E. Vitali, V. Dattilo, et al. · European Neuropsychopharmacology
Polymorphisms of SLC6A4, 5-HT2A and 5-HT6 genes and therapeutic resistance in schizophrenic inpatients
2002 · A. Saltini, C. Bonvicini, et al. · European Neuropsychopharmacology
The use of novel antipsychotics to improve response in schizophrenia: a naturalistic study in poor responders
2000 · A.C. Altamura, E. Mundo, et al. · European Neuropsychopharmacology
Haptoglobin phenotypes and genotypes in schizophrenia
2000 · M. Maes, L. Bocchio, et al. · European Neuropsychopharmacology
Longitudinal changes of plasma HVA and 5-HIAA levels in schizophrenic patients resistant to neuroleptics
1999 · L.Bocchio Chiavetto, S. Bignotti, et al. · European Neuropsychopharmacology
Immune modulation in resistant schizophrenic patients during long-term neuroleptic treatment
1997 · S. Bignotti, G.B. Tura, et al. · Biological Psychiatry
Works count: 27
Citation count: 3,351
H-index: 6
I10-index: 5
Year
Topic
Type